Notable Variants of SARS-CoV-2
##plugins.themes.bootstrap3.article.main##
The current coronavirus pandemic has brought many deaths and affected economies around the world. The causative agent of COVID-19 is identified as SARS-CoV-2, a close relative to SARS-CoV that caused an outbreak of severe acute respiratory distress in 2002-2003. During the course of the pandemic, there has been many reports of mutations that occurred to SARS-CoV-2 with several lineages that has been identified around the globe. In this paper, a summary of the notable variants of SARS-CoV-2 is discussed.
Downloads
Download data is not yet available.
References
-
World Health Organization. (2020). Weekly Epidemiological Update - 29 December 2020. Retrieved February 15, 2021, from https://www.who.int/publications/m/item/weekly-epidemiological-update---29-december-2020.
Google Scholar
1
-
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet (London, England), 6736(20), 1–10. https://doi.org/10.1016/S0140-6736(20)30251-8.
DOI | Google Scholar
2
-
Pereira, F. (2020). Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene. Infection, Genetics and Evolution. https://doi.org/10.1016/j.meegid.2020.104525.
DOI | Google Scholar
3
-
Centers for Disease Control and Prevention (CDC). (2021). Genomic Surveillance for SARS-CoV-2 Variants. Retrived February 15, 2021 from https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/variant-surveillance.html
Google Scholar
4
-
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C. C., Bieniasz, P. D. (2020). Escape from neutralizing antibodies 1 by SARS-CoV-2 spike protein variants. ELife. https://doi.org/10.7554/eLife.61312.
DOI | Google Scholar
5
-
Koyama, T., Platt, D., & Parida, L. (2020). Variant analysis of SARS-cov-2 genomes. Bulletin of the World Health Organization. https://doi.org/10.2471/BLT.20.253591.
DOI | Google Scholar
6
-
Voloch, C. M., da Silva Francisco, R., de Almeida, L. G. P., Cardoso, C. C., Brustolini, O. J., Gerber, A. L., de Faria Cavalcante, L. T. (2020). Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. MedRxiv. https://doi.org/10.1101/2020.12.23.20248598.
DOI | Google Scholar
7
-
Rambaut, A., Loman, N., Pybus, O., Barclay, W., Barrett, J., Carabelli, A., Volz, E. (2020). Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological.Org.
Google Scholar
8
-
Gu, H., Chen, Q., Yang, G., He, L., Fan, H., Deng, Y. Q., Zhou, Y. (2020). Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy. Science. https://doi.org/10.1126/science.abc4730.
DOI | Google Scholar
9
-
Kemp, S. A., Datir, R. P., Collier, D. A., Ferreira, I. A. T. M., Carabelli, A., Harvey, W., Gupta, R. K. (2020). Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ∆H69/V70. BioRxiv. https://doi.org/10.1101/2020.12.14.422555.
DOI | Google Scholar
10
-
Wu, K., Werner, A. P., Moliva, J. I., Koch, M., Choi, A., Stewart-Jones, G. B. E., Edwards, D. K. (2021). mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants. BioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2021.01.25.427948.
DOI | Google Scholar
11
-
Collier, D., Meng, B., Ferreira, I., Datir, R., Temperton, N. J., Elmer, A., Gupta, R. (2021). Impact of SARS-CoV-2 B.1.1.7 Spike variant on neutralisation potency of sera from individuals vaccinated with Pfizer vaccine BNT162b2. MedRxiv.
Google Scholar
12
-
Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Lambson, B. E., Moore, P. L. (2021). SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma. BioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2021.01.18.427166.
DOI | Google Scholar
13
-
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Montefiori, D. C. (2020). Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. https://doi.org/10.1016/j.cell.2020.06.043.
DOI | Google Scholar
14
-
Horby, P., Huntley, C., Davies, N., Edmunds, J., Ferguson, N., Medley, G., Semple, C. (2021). NERVTAG note on B.1.1.7 severity. SAGE.
Google Scholar
15
-
European Centre for Disease Prevention and Control (ECDC). (2020). Detection of new SARS-CoV-2 variants related to mink. ECDC: Stockholm; 2020.
Google Scholar
16
-
National Institute of Infectious Diseases, Japan. (2021). New VARIANT strain OF SARS-CoV-2 identified in travelers from Brazil. (2021, January 12). Retrieved February 15, 2021, from https://www.niid.go.jp/niid/en/2019-ncov-e/10108-covid19-33-en.html.
Google Scholar
17
-
Sabino, E. C., Buss, L. F., Carvalho, M. P. S., Prete, C. A., Crispim, M. A. E., Fraiji, N. A., Faria, N. R. (2021). Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet. https://doi.org/10.1016/s0140-6736(21)00183-5.
DOI | Google Scholar
18
-
Resende, P. C., Bezerra, J. F., Teixeira de Vasconcelos, R. H., Arantes, I., Appolinario, L., Mendonça, A. C., Siqueira, M. M. (2021). Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil, 2020 - SARS-CoV-2 coronavirus / nCoV-2019 Genomic Epidemiology - Virological. Virological.
Google Scholar
19
Most read articles by the same author(s)
-
Hassan Naji,
Comparative Analysis of COVID-19 Vaccines , European Journal of Medical and Health Sciences: Vol. 3 No. 1 (2021) -
Hassan Naji,
Long-Term Effects of COVID-19: A Systemic Review , European Journal of Medical and Health Sciences: Vol. 4 No. 4 (2022) -
Hassan Naji,
Neurologic Manifestations of SARS-CoV-2, the Virus that Causes COVID-19 , European Journal of Medical and Health Sciences: Vol. 2 No. 6 (2020) -
Hassan Naji,
COVID-19: Anatomy of a Pandemic , European Journal of Medical and Health Sciences: Vol. 3 No. 4 (2021) -
Hassan Naji,
Monkeypox Virus: Transmission, Signs and Symptoms, Prevention, and Epidemiology , European Journal of Medical and Health Sciences: Vol. 4 No. 5 (2022) -
Hassan Naji,
Epidemiology and Vaccine Efficacy of Delta Variant , European Journal of Medical and Health Sciences: Vol. 3 No. 6 (2021)